NTLA - Intellia Therapeutics, Inc.

QQQ $ 608.10 nm (nm)

DIA $ 475.40 $ -8.02 (-1.66 %)

SPY $ 672.11 nm (nm)

TLT $ 89.41 nm (nm)

GLD $ 383.72 $ -3.12 (-0.81 %)

Previous Close

$ 9.49

Open

$ 9.33

Bid

$ 8.63 x 15

Ask

$ 8.65 x 69

Day's Range

$ 8.57 - $ 9.62

52 Week Range

$ 5.90 - $ 28.25

Volume

9,483,588

Average Volume

Market Cap

1.1B

Beta (5Y Monthly)

$ 2.35

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-06-2025	09-30-2025	10-Q
2	08-07-2025	06-30-2025	10-Q
3	05-08-2025	03-31-2025	10-Q
4	02-27-2025	12-31-2024	10-K
5	11-07-2024	09-30-2024	10-Q
6	08-08-2024	06-30-2024	10-Q
7	05-09-2024	03-31-2024	10-Q
8	02-22-2024	12-31-2023	10-K
9	11-09-2023	09-30-2023	10-Q
10	08-03-2023	06-30-2023	10-Q
11	05-04-2023	03-31-2023	10-Q
12	02-23-2023	12-31-2022	10-K
13	11-03-2022	09-30-2022	10-Q
14	08-04-2022	06-30-2022	10-Q
15	05-05-2022	03-31-2022	10-Q
16	02-24-2022	12-31-2021	10-K
17	11-04-2021	09-30-2021	10-Q
18	08-05-2021	06-30-2021	10-Q
19	05-06-2021	03-31-2021	10-Q
20	02-26-2021	12-31-2020	10-K
21	11-05-2020	09-30-2020	10-Q
22	08-06-2020	06-30-2020	10-Q
23	05-07-2020	03-31-2020	10-Q
24	02-27-2020	12-31-2019	10-K
25	10-31-2019	09-30-2019	10-Q
26	08-01-2019	06-30-2019	10-Q
27	05-02-2019	03-31-2019	10-Q
28	02-27-2019	12-31-2018	10-K
29	10-31-2018	09-30-2018	10-Q
30	08-01-2018	06-30-2018	10-Q
31	05-01-2018	03-31-2018	10-Q
32	03-14-2018	12-31-2017	10-K
33	10-31-2017	09-30-2017	10-Q
34	08-01-2017	06-30-2017	10-Q
35	05-02-2017	03-31-2017	10-Q
36	03-14-2017	12-31-2016	10-K
37	11-01-2016	09-30-2016	10-Q
38	08-04-2016	06-30-2016	10-Q
39	06-03-2016	03-31-2016	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

this-bath--body-works-analyst-is-no-longer-bullish-here-are-top-4-downgrades-for-wednesday

This Bath & Body Works Analyst Is No Longe...
11/12/2025 14:00:27

Wolfe Research Downgrades Intellia Therape...
11/12/2025 12:00:30

Wolfe Research analyst Andy Chen downgrades Intellia Therapeutics (NASDAQ:NTLA) from Outperform to Peer Perform.

Jones Trading Downgrades Intellia Therapeu...
11/11/2025 19:54:11

Jones Trading analyst Debanjana Chatterjee downgrades Intellia Therapeutics (NASDAQ:NTLA) from Buy to Hold.

this-sps-commerce-analyst-is-no-longer-bullish-here-are-top-3-downgrades-for-tuesday

This SPS Commerce Analyst Is No Longer Bul...
11/11/2025 12:05:53

What 21 Analyst Ratings Have To Say About ...
11/11/2025 11:45:05

Evercore ISI Group Downgrades Intellia The...
11/11/2025 10:15:28

Evercore ISI Group analyst Jonathan Miller downgrades Intellia Therapeutics (NASDAQ:NTLA) from Outperform to In-Line and low...

Intellia Therapeutics Presents Follow-Up D...
11/10/2025 20:22:20

One-time treatment of nex-z led to consistently rapid, deep and durable reduction in serum TTR through three years of follow-up...

Truist Securities Reiterates Buy on Intell...
11/10/2025 16:45:43

Truist Securities analyst Joon Lee reiterates Intellia Therapeutics (NASDAQ:NTLA) with a Buy and lowers the price target fro...

HC Wainwright & Co. Maintains Buy on Intel...
11/10/2025 12:32:10

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Intellia Therapeutics (NASDAQ:NTLA) with a Buy and lowers the p...

Reported Saturday, Intellia Therapeutics P...
11/10/2025 08:56:25

Deep, stable and durable reductions in kallikrein observed Among 32 patients who received a 50 mg dose of lonvo-z as of data cu...

Chardan Capital Maintains Buy on Intellia ...
11/07/2025 23:10:46

Chardan Capital analyst Geulah Livshits maintains Intellia Therapeutics (NASDAQ:NTLA) with a Buy and lowers the price target...

RBC Capital Maintains Sector Perform on In...
11/07/2025 19:10:23

RBC Capital analyst Luca Issi maintains Intellia Therapeutics (NASDAQ:NTLA) with a Sector Perform and lowers the price targe...

Wells Fargo Maintains Equal-Weight on Inte...
11/07/2025 18:56:23

Wells Fargo analyst Yanan Zhu maintains Intellia Therapeutics (NASDAQ:NTLA) with a Equal-Weight and lowers the price target ...

12 Health Care Stocks Moving In Friday's I...
11/07/2025 17:05:53

Barclays Maintains Overweight on Intellia ...
11/07/2025 15:28:29

Barclays analyst Gena Wang maintains Intellia Therapeutics (NASDAQ:NTLA) with a Overweight and lowers the price target from ...

Wedbush Maintains Neutral on Intellia Ther...
11/07/2025 15:08:52

Wedbush analyst David Nierengarten maintains Intellia Therapeutics (NASDAQ:NTLA) with a Neutral and lowers the price target ...

Citizens Maintains Market Outperform on In...
11/07/2025 13:52:54

Citizens analyst Silvan Tuerkcan maintains Intellia Therapeutics (NASDAQ:NTLA) with a Market Outperform and lowers the price...

JP Morgan Downgrades Intellia Therapeutics...
11/07/2025 12:15:03

JP Morgan analyst Brian Cheng downgrades Intellia Therapeutics (NASDAQ:NTLA) from Neutral to Underweight and lowers the pric...

12 Health Care Stocks Moving In Friday's P...
11/07/2025 12:05:44

block-posts-downbeat-q3-results-joins-archer-aviation-draftkings-and-other-big-stocks-moving-lower-in-fridays-pre-market-session

Block Posts Downbeat Q3 Results, Joins Arc...
11/07/2025 11:29:18